Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA) Dividend History

Company News

• Kiniksa Pharmaceuticals Announces Trial Design of Planned Phase 2/3 Clinical Trial of KPL-387 in Recurrent Pericarditis

  Kiniksa Pharmaceuticals announces plans for a Phase 2/3 clinical trial of its drug KPL-387 in recurrent pericarditis, with the trial expected to initiate in mid-2025 and Phase 2 data expected in the second half of 2026.

  GlobeNewswire Inc.
• 3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now

  The article highlights three healthcare stocks that are considered good investments right now: AbbVie, Vertex Pharmaceuticals, and Kiniksa Pharmaceuticals. It discusses the growth prospects and financial metrics of these companies.

  The Motley Fool

  Featured Companies: ABBV VRTX
• Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q1 Loss, Tops Revenue Estimates

  Kiniksa Pharmaceuticals (KNSA) delivered earnings and revenue surprises of -78.57% and 4.05%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research

  Featured Companies: MYNZ
• Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

  Shares of Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) rose sharply during Tuesday’s session after the company released topline data from the PACIFIC Phase 1b/2a study evaluating bexicaserin (LP352) for seizures associated with a broad range of Developmental and Epileptic Encephalopathies (DEEs). Longboard Pharmaceuticals shares jumped 199.7% to $18.07 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers Akso Health Group (NASDAQ: AHG) surged 85% to $1.2946. Polished.com Inc. (NYSE: POL) gained 45% to $8.77. Dogness (International) Corporation (NASDAQ: DOGZ) jumped 40% to $7.42. Cue Health Inc. (NASDAQ: HLTH) gained 36.8% to $0.2224 after falling 42% on Friday. Voyager Therapeutics, Inc. (NASDAQ: VYGR) surged 34% to $11.38 after the company announced a strategic collaboration and capsid license agreement with Novartis to advance potential gene therapies for Huntington's disease and spinal muscular atrophy. RiskOn International, Inc. (NASDAQ: ROI) shares climbed 33.5% to $0.4450 after gaining around 17% on Friday. RiskOn International recently said it expects to announce its new generative AI platform and unveil a principal technology partner on Jan. 3. Soligenix, Inc. (NASDAQ: SNGX) shares gained 33.4% to $1.01. Soligenix announced publication demonstrating complete protection against filovirus disease in nonhuman primate models of ebola and marburg viruses. SenesTech, Inc. (NASDAQ: SNES) gained 22.2% to $1.56. SenesTech announced the expansion of its distribution agreement with Pesterminators Pvt Ltd to include the deployment of EvolveTM. Brooge Energy Limited (NASDAQ: BROG) jumped 17.1% to $4.31. Brooge Energy recently announced that it reached a settlement with the SEC where it agreed to pay a $5 million penalty and cease any future violations. Lyell Immunopharma, Inc. (NASDAQ: LYEL) gained 16.9% to $2.26. Wheels Up Experience Inc. (NYSE:

  Benzinga

  Featured Companies: ADTX ALLO AMPX AOSL AUR AVXL BROG BTCS BTDR CLSK CORT DOGZ GDRX HUT KORE LYEL MARA MNKD MOBX MRNA MSTR PGEN RIOT RIVN RNXT SNES SNGX SNTG SXTC UP VSTE VYGR
• Wall Street Breakfast: What Moved Markets

  Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify.

  Seeking Alpha

  Featured Companies: AMAT APA APTV DG EL ETSY GOOG GOOGL HAL HOOD ILMN LUMN LVS TSLA UTHR